LeMaitre Vascular, Inc. (LMAT) to Issue Quarterly Dividend of $0.25 on March 26th

LeMaitre Vascular, Inc. (NASDAQ:LMAT) declared a quarterly dividend on Thursday, February 19th. Shareholders of record on Thursday, March 12th will be given a dividend of 0.25 per share by the medical instruments supplier on Thursday, March 26th. This represents a c) dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Thursday, March 12th. This is a 25.0% increase from LeMaitre Vascular’s previous quarterly dividend of $0.20.

LeMaitre Vascular has increased its dividend payment by an average of 0.2%annually over the last three years and has raised its dividend every year for the last 14 years. LeMaitre Vascular has a payout ratio of 42.0% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect LeMaitre Vascular to earn $2.17 per share next year, which means the company should continue to be able to cover its $1.00 annual dividend with an expected future payout ratio of 46.1%.

LeMaitre Vascular Price Performance

LMAT stock traded down $0.66 during trading on Tuesday, hitting $109.41. 6,486 shares of the company’s stock traded hands, compared to its average volume of 186,084. The company has a debt-to-equity ratio of 0.43, a quick ratio of 10.95 and a current ratio of 12.89. The business has a fifty day simple moving average of $89.84 and a 200 day simple moving average of $88.81. The stock has a market capitalization of $2.49 billion, a price-to-earnings ratio of 43.61, a P/E/G ratio of 3.09 and a beta of 0.66. LeMaitre Vascular has a 52 week low of $71.42 and a 52 week high of $115.33.

LeMaitre Vascular (NASDAQ:LMAT) last released its quarterly earnings results on Wednesday, February 25th. The medical instruments supplier reported $0.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.01. LeMaitre Vascular had a net margin of 23.13% and a return on equity of 14.72%. The firm had revenue of $64.45 million for the quarter, compared to analysts’ expectations of $62.98 million. During the same quarter last year, the company earned $0.49 EPS. The firm’s revenue for the quarter was up 15.7% compared to the same quarter last year. LeMaitre Vascular has set its FY 2026 guidance at 2.810-3.010 EPS and its Q1 2026 guidance at 0.640-0.690 EPS. As a group, research analysts expect that LeMaitre Vascular will post 1.94 EPS for the current fiscal year.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.